BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34773312)

  • 1. Increased body mass index predicts prolonged survival in patients with head and neck squamous cell carcinoma.
    Wu EL; Peesay T; Randall JA; Nelson LL; Shearer SC; Johnson BC; Maxwell JH
    Head Neck; 2022 Feb; 44(2):325-331. PubMed ID: 34773312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of obesity on outcomes for patients with head and neck cancer.
    Hicks DF; Bakst R; Doucette J; Kann BH; Miles B; Genden E; Misiukiewicz K; Posner M; Gupta V
    Oral Oncol; 2018 Aug; 83():11-17. PubMed ID: 30098765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Body Mass Index Paradox in Head and Neck Cancer: A Systematic Review and Meta-Analysis.
    Hobday S; Armache M; Paquin R; Nurimba M; Baddour K; Linder D; Kouame G; Tharrington S; Albergotti WG; Mady LJ
    Nutr Cancer; 2023; 75(1):48-60. PubMed ID: 35959747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between body mass index and efficacy of pembrolizumab as second-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma.
    Zhang X; Rui M; Lin C; Li Z; Wei D; Han R; Ju H; Ren G
    Cancer Med; 2023 Feb; 12(3):2702-2712. PubMed ID: 35975731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Body Mass Index With Outcomes Among Patients With Head and Neck Cancer Treated With Chemoradiotherapy.
    Ma SJ; Khan M; Chatterjee U; Santhosh S; Hashmi M; Gill J; Yu B; Iovoli A; Farrugia M; Wooten K; Gupta V; McSpadden R; Yu H; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Seshadri M; Ray AD; Repasky E; Singh AK
    JAMA Netw Open; 2023 Jun; 6(6):e2320513. PubMed ID: 37368400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment dietary patterns, weight status, and head and neck squamous cell carcinoma prognosis.
    Arthur AE; Peterson KE; Rozek LS; Taylor JM; Light E; Chepeha DB; Hébert JR; Terrell JE; Wolf GT; Duffy SA;
    Am J Clin Nutr; 2013 Feb; 97(2):360-8. PubMed ID: 23269814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index and prognosis in patients with head and neck cancer.
    Gama RR; Song Y; Zhang Q; Brown MC; Wang J; Habbous S; Tong L; Huang SH; O'Sullivan B; Waldron J; Xu W; Goldstein D; Liu G
    Head Neck; 2017 Jun; 39(6):1226-1233. PubMed ID: 28323362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer.
    Fattouh M; Chang GY; Ow TJ; Shifteh K; Rosenblatt G; Patel VM; Smith RV; Prystowsky MB; Schlecht NF
    Head Neck; 2019 Mar; 41(3):707-714. PubMed ID: 30582237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment fat-free mass index correlates with early death in patients with head and neck squamous cell carcinoma.
    Talani C; Astradsson T; Farnebo L; Mäkitie A; Ehrsson YT; Laurell G
    Head Neck; 2024 Apr; 46(4):808-818. PubMed ID: 38193618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal BMI predicts the survival benefits of inductive docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced oral squamous cell carcinoma.
    Zhao TC; Liang SY; Ju WT; Liu Y; Tan YR; Zhu DW; Zhang CP; Zhang ZY; Zhong LP
    Clin Nutr; 2020 Sep; 39(9):2751-2758. PubMed ID: 31839432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma.
    Lim WS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    Laryngoscope; 2017 Dec; 127(12):E437-E442. PubMed ID: 28561532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
    Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
    JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of obesity on the survival of patients with early-stage squamous cell carcinoma of the oral tongue.
    Iyengar NM; Kochhar A; Morris PG; Morris LG; Zhou XK; Ghossein RA; Pino A; Fury MG; Pfister DG; Patel SG; Boyle JO; Hudis CA; Dannenberg AJ
    Cancer; 2014 Apr; 120(7):983-91. PubMed ID: 24449483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer.
    Jung AR; Roh JL; Kim JS; Kim SB; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2019 Jul; 116():98-106. PubMed ID: 31185387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of COVID-19 and vaccination status on outcomes in veterans with head and neck squamous cell carcinoma.
    Johns JD; Choe EJ; Chisolm PF; Pothast MJ; Randolph JR; Chou J; Maxwell JH
    Head Neck; 2024 Jul; 46(7):1698-1705. PubMed ID: 38433326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of body mass index before treatment for head and neck cancer.
    Takenaka Y; Takemoto N; Nakahara S; Yamamoto Y; Yasui T; Hanamoto A; Fukusumi T; Michiba T; Cho H; Yamamoto M; Inohara H
    Head Neck; 2015 Oct; 37(10):1518-23. PubMed ID: 24890618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy.
    Moon H; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Radiother Oncol; 2016 Feb; 118(2):330-4. PubMed ID: 26653356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment ADC is not a prognostic factor for local recurrences in head and neck squamous cell carcinoma when clinical T-stage is known.
    Peltenburg B; Driessen JP; Vasmel JE; Pameijer FA; Janssen LM; Terhaard CHJ; de Bree R; Philippens MEP
    Eur Radiol; 2020 Feb; 30(2):1228-1231. PubMed ID: 31529258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
    Elbers JBW; Al-Mamgani A; van den Brekel MWM; Jóźwiak K; de Boer JP; Lohuis PJFM; Willems SM; Verheij M; Zuur CL
    Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1023-1033. PubMed ID: 30526317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes in veterans with HPV-positive head and neck cancer.
    Feinstein AJ; Shay SG; Chang E; Lewis MS; Wang MB
    Am J Otolaryngol; 2017; 38(2):188-192. PubMed ID: 28342482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.